| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, FIN-33101 Tampere, Finland [P. K., M. B.], and Cancer Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892 [O. M., A. K.]
Amplification of the ERBB2 oncogene at 17q12 has been well documented in breast cancer and has been shown to contribute to a poor clinical outcome. However, systematic surveys of copy number and expression levels of all genes within the 17q12 region have not been performed. Here, we used cDNA and comparative genomic hybridization microarray technologies to undertake a broad survey of genes involved in the 17q12 amplification in breast cancer. A chromosomal region-specific cDNA microarray containing 217 expressed sequence tag (EST) clones from 17q12 was constructed and used for parallel analysis of gene copy numbers and expression levels in seven breast cancer cell lines allowing direct identification of genes whose expression is elevated because of an increase in copy number in this chromosomal region. The copy number and expression survey identified 12 transcripts that showed a consistent pattern of increased copy number and expression in three or more of the 17q12-amplified cell lines. As expected, these included ERBB2 as well as the GRB7 and MLN64 genes previously shown to be coamplified with ERBB2. In addition, five other known genes and four uncharacterized ESTs were also found to be consistently activated by amplification in these breast cancer cell lines. Amplicon mapping by fluorescence in situ hybridization revealed a minimal common region of amplification containing four highly expressed genes, ERBB2, GRB7, MLN64, and an uncharacterized EST 48582. Furthermore, several other genes, although not located in the minimal common region of amplification, showed a correlated pattern of amplification and expression indicating that they might play a role in breast cancers with the 17q12 amplification. In conclusion, parallel analysis of gene copy number and expression levels by cDNA microarray can be used to directly identify candidate target genes involved in amplifications. Our results show that the 17q12 amplification in breast cancer leads to the simultaneous elevation of expression levels of several genes.
This article has been cited by other articles:
![]() |
D. R. Rhodes, B. Ateeq, Q. Cao, S. A. Tomlins, R. Mehra, B. Laxman, S. Kalyana-Sundaram, R. J. Lonigro, B. E. Helgeson, M. S. Bhojani, et al. AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist PNAS, June 23, 2009; 106(25): 10284 - 10289. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xiang, K. Chatti, H. Qiu, B. Lakshmi, A. Krasnitz, J. Hicks, M. Yu, W. T. Miller, and S. K. Muthuswamy Brk is coamplified with ErbB2 to promote proliferation in breast cancer PNAS, August 26, 2008; 105(34): 12463 - 12468. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Iakovlev, N. C.R. Arneson, V. Wong, C. Wang, S. Leung, G. Iakovleva, K. Warren, M. Pintilie, and S. J. Done Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study Clin. Cancer Res., July 15, 2008; 14(14): 4446 - 4454. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bai and S.-W. Luoh GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation Carcinogenesis, March 1, 2008; 29(3): 473 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Buness, R. Kuner, M. Ruschhaupt, A. Poustka, H. Sultmann, and A. Tresch Identification of aberrant chromosomal regions from gene expression microarray studies applied to human breast cancer Bioinformatics, September 1, 2007; 23(17): 2273 - 2280. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Yang, K. L. Streicher, M. E. Ray, J. Abrams, and S. P. Ethier Multiple Interacting Oncogenes on the 8p11-p12 Amplicon in Human Breast Cancer Cancer Res., December 15, 2006; 66(24): 11632 - 11643. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Maqani, A. Belkhiri, C. Moskaluk, S. Knuutila, A. A. Dar, and W. El-Rifai Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal Adenocarcinomas Mol. Cancer Res., July 1, 2006; 4(7): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanner, J. Isola, T. Wiklund, B. Erikstein, P. Kellokumpu-Lehtinen, P. Malmstrom, N. Wilking, J. Nilsson, and J. Bergh Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401 J. Clin. Oncol., June 1, 2006; 24(16): 2428 - 2436. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yao, S. Weremowicz, B. Feng, R. C. Gentleman, J. R. Marks, R. Gelman, C. Brennan, and K. Polyak Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res., April 15, 2006; 66(8): 4065 - 4078. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Kauraniemi and A Kallioniemi Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer. Endocr. Relat. Cancer, March 1, 2006; 13(1): 39 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fiegl, S. Millinger, G. Goebel, E. Muller-Holzner, C. Marth, P. W. Laird, and M. Widschwendter Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer Cancer Res., January 1, 2006; 66(1): 29 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Juric, S. Sale, R. A. Hromas, R. Yu, Y. Wang, G. E. Duran, R. Tibshirani, L. H. Einhorn, and B. I. Sikic Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures PNAS, December 6, 2005; 102(49): 17763 - 17768. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano Sex steroid-producing enzymes in human breast cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Alpy and C. Tomasetto Give lipids a START: the StAR-related lipid transfer (START) domain in mammals J. Cell Sci., July 1, 2005; 118(13): 2791 - 2801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Levin, D. Ghosh, K. R. Cho, and S. L. R. Kardia A model-based scan statistic for identifying extreme chromosomal regions of gene expression in human tumors Bioinformatics, June 15, 2005; 21(12): 2867 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Alpy, V. K. Latchumanan, V. Kedinger, A. Janoshazi, C. Thiele, C. Wendling, M.-C. Rio, and C. Tomasetto Functional Characterization of the MENTAL Domain J. Biol. Chem., May 6, 2005; 280(18): 17945 - 17952. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. M. Loo, D. I. Grove, E. M. Williams, C. L. Neal, L. A. Cousens, E. L. Schubert, I. N. Holcomb, H. F. Massa, J. Glogovac, C. I. Li, et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes Cancer Res., December 1, 2004; 64(23): 8541 - 8549. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Dahlberg, B. A. Jacobson, G. Dahal, J. M. Fink, R. A. Kratzke, M. A. Maddaus, and L. J. Ferrin ERBB2 Amplifications in Esophageal Adenocarcinoma Ann. Thorac. Surg., November 1, 2004; 78(5): 1790 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Orsetti, M. Nugoli, N. Cervera, L. Lasorsa, P. Chuchana, L. Ursule, C. Nguyen, R. Redon, S. du Manoir, C. Rodriguez, et al. Genomic and Expression Profiling of Chromosome 17 in Breast Cancer Reveals Complex Patterns of Alterations and Novel Candidate Genes Cancer Res., September 15, 2004; 64(18): 6453 - 6460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Degot, H. Le Hir, F. Alpy, V. Kedinger, I. Stoll, C. Wendling, B. Seraphin, M.-C. Rio, and C. Tomasetto Association of the Breast Cancer Protein MLN51 with the Exon Junction Complex via Its Speckle Localizer and RNA Binding Module J. Biol. Chem., August 6, 2004; 279(32): 33702 - 33715. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ross, J. A. Fletcher, K. J. Bloom, G. P. Linette, J. Stec, W. F. Symmans, L. Pusztai, and G. N. Hortobagyi Targeted Therapy in Breast Cancer: The HER-2/neu Gene and Protein Mol. Cell. Proteomics, April 1, 2004; 3(4): 379 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Ray, Z. Q. Yang, D. Albertson, C. G. Kleer, J. G. Washburn, J. A. Macoska, and S. P. Ethier Genomic and Expression Analysis of the 8p11-12 Amplicon in Human Breast Cancer Cell Lines Cancer Res., January 1, 2004; 64(1): 40 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kauraniemi, T. Kuukasjarvi, G. Sauter, and A. Kallioniemi Amplification of a 280-Kilobase Core Region at the ERBB2 Locus Leads to Activation of Two Hypothetical Proteins in Breast Cancer Am. J. Pathol., November 1, 2003; 163(5): 1979 - 1984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gariboldi, M. Spinola, S. Milani, C. Pignatiello, K. Kadota, H. Bono, Y. Hayashizaki, T. A. Dragani, and Y. Okazaki Gene expression profile of normal lungs predicts genetic predisposition to lung cancer in mice Carcinogenesis, November 1, 2003; 24(11): 1819 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, S.-M. Luoh, Y. Zhang, C. Watanabe, T. D. Wu, M. Ostland, W. I. Wood, and Z. Zhang Genome-wide Identification of Chromosomal Regions of Increased Tumor Expression by Transcriptome Analysis Cancer Res., September 15, 2003; 63(18): 5781 - 5784. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Andrechek, M. A. Laing, A. A. Girgis-Gabardo, P. M. Siegel, R. D. Cardiff, and W. J. Muller Gene Expression Profiling of Neu-induced Mammary Tumors from Transgenic Mice Reveals Genetic and Morphological Similarities to ErbB2-expressing Human Breast Cancers Cancer Res., August 15, 2003; 63(16): 4920 - 4926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Alaoui-Jamali, D. J. Song, N. Benlimame, L. Yen, X. Deng, M. Hernandez-Perez, and T. Wang Regulation of Multiple Tumor Microenvironment Markers by Overexpression of Single or Paired Combinations of ErbB Receptors Cancer Res., July 1, 2003; 63(13): 3764 - 3774. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Dressman, A. Baras, R. Malinowski, L. B. Alvis, I. Kwon, T. M. Walz, and M. H. Polymeropoulos Gene Expression Profiling Detects Gene Amplification and Differentiates Tumor Types in Breast Cancer Cancer Res., May 1, 2003; 63(9): 2194 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jeruss, N. X. Liu, Y. Chung, G. Magrane, F. Waldman, S. Edgerton, X. Yang, and A. D. Thor Characterization and chromosomal instability of novel derived cell lines from a wt-erbB-2 transgenic mouse model Carcinogenesis, April 1, 2003; 24(4): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Alpy, C. Wendling, M.-C. Rio, and C. Tomasetto MENTHO, a MLN64 Homologue Devoid of the START Domain J. Biol. Chem., December 20, 2002; 277(52): 50780 - 50787. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Climent, J. A. Martinez-Climent, D. Blesa, M. J. Garcia-Barchino, R. Saez, D. Sanchez-Izquierdo, P. Azagra, A. Lluch, and J. Garcia-Conde Genomic Loss of 18p Predicts an Adverse Clinical Outcome in Patients with High-Risk Breast Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3863 - 3869. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hyman, P. Kauraniemi, S. Hautaniemi, M. Wolf, S. Mousses, E. Rozenblum, M. Ringner, G. Sauter, O. Monni, A. Elkahloun, et al. Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer Cancer Res., November 1, 2002; 62(21): 6240 - 6245. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Wilson, H. Roberts, R. Leek, A. L. Harris, and J. Geradts Differential Gene Expression Patterns in HER2/neu-Positive and -Negative Breast Cancer Cell Lines and Tissues Am. J. Pathol., October 1, 2002; 161(4): 1171 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Schouten, C. J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, and G. Pals Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification Nucleic Acids Res., June 15, 2002; 30(12): e57 - e57. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varis, M. Wolf, O. Monni, M.-L. Vakkari, A. Kokkola, C. Moskaluk, H. Frierson Jr., S. M. Powell, S. Knuutila, A. Kallioniemi, et al. Targets of Gene Amplification and Overexpression at 17q in Gastric Cancer Cancer Res., May 1, 2002; 62(9): 2625 - 2629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Jeffrey, M. J. Fero, A.-L. Borresen-Dale, and D. Botstein Expression Array Technology in the Diagnosis and Treatment of Breast Cancer Mol. Interv., April 1, 2002; 2(2): 101 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Skotheim, O. Monni, S. Mousses, S. D. Fossa, O.-P. Kallioniemi, R. A. Lothe, and A. Kallioniemi New Insights into Testicular Germ Cell Tumorigenesis from Gene Expression Profiling Cancer Res., April 1, 2002; 62(8): 2359 - 2364. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |